Related Experiment Video
Updated: Oct 20, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer
Nam Hee Kim1, Sang Hyun Song1, Yun Hee Choi1
1Department of Oral Pathology, Yonsei University College of Dentistry, Seoul 03722, Korea.
Abstract:
The epithelial-mesenchymal transition (EMT) comprises an important biological mechanism not only for cancer progression but also in the therapeutic resistance of cancer cells. While the importance of the protein abundance of EMT-inducers, such as Snail (SNAI1) and Zeb1 (ZEB1), during EMT progression is clear, the reciprocal interactions between the untranslated regions (UTRs) of EMT-inducers via a competing endogenous RNA (ceRNA) network have received little attention. In this study, we found a synchronized transcript abundance of Snail and Zeb1 mediated by a non-coding RNA network in colorectal cancer (CRC). Importantly, the trans-regulatory ceRNA network in the UTRs of EMT inducers is mediated by competition between tumor suppressive miRNA-34 (miR-34) and miRNA-200 (miR-200). Furthermore, the ceRNA network consisting of the UTRs of EMT inducers and tumor suppressive miRs is functional in the EMT phenotype and therapeutic resistance of colon cancer. In The Cancer Genome Atlas (TCGA) samples, we also found genome-wide ceRNA gene sets regulated by miR-34a and miR-200 in colorectal cancer. These results indicate that the ceRNA networks regulated by the reciprocal interaction between EMT gene UTRs and tumor suppressive miRs are functional in CRC progression and therapeutic resistance.
Insights
The epithelial-mesenchymal transition (EMT) involves competing endogenous RNA (ceRNA) networks in colorectal cancer. These networks, involving EMT-inducers and tumor suppressive microRNAs, impact cancer progression and therapeutic resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The epithelial-mesenchymal transition (EMT) is crucial for cancer progression and therapeutic resistance.
- Protein abundance of EMT-inducers like Snail and Zeb1 is well-studied, but interactions via untranslated regions (UTRs) in competing endogenous RNA (ceRNA) networks are less understood.
Purpose of the Study:
- To investigate the role of ceRNA networks in regulating EMT-inducers Snail and Zeb1 in colorectal cancer (CRC).
- To explore the functional impact of these ceRNA networks on EMT phenotype and therapeutic resistance in colon cancer.
Main Methods:
- Analysis of synchronized transcript abundance of Snail and Zeb1.
- Identification of a trans-regulatory ceRNA network involving UTRs of EMT inducers and tumor suppressive miRNAs (miR-34, miR-200).
- Examination of The Cancer Genome Atlas (TCGA) samples for genome-wide ceRNA gene sets regulated by miR-34a and miR-200.
Main Results:
- A non-coding RNA network synchronizes Snail and Zeb1 transcript abundance in colorectal cancer.
- A trans-regulatory ceRNA network mediated by miR-34 and miR-200 competition within EMT inducer UTRs was identified.
- This ceRNA network was found to be functional in the EMT phenotype and therapeutic resistance of colon cancer.
- Genome-wide ceRNA gene sets regulated by miR-34a and miR-200 were observed in TCGA colorectal cancer samples.
Conclusions:
- ceRNA networks involving reciprocal interactions between EMT gene UTRs and tumor suppressive microRNAs are functional in colorectal cancer progression.
- These networks play a significant role in the therapeutic resistance of colorectal cancer cells.
- Understanding these ceRNA networks offers potential therapeutic targets for colorectal cancer.
Related Concept Videos
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Non-LTR Retrotransposons
RNA Splicing

